Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty

NEXT STORY
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
PREV STORY
Global Advanced Wound Management (AWM) Technology Markets, 2021-2026 – Increasing Acceptance of Innovative Technologies and Protocols for Complex Wound Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Recent 24-Month Real-World PALADIN Data Demonstrate the Ability of ILUVIEN® to Significantly Reduce Treatment Burden in Patients with Diabetic Macular Edema

author_avatar
NASDAQ Market News

Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Tyme Announces Interim Phase II Safety and Efficacy Data for SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium

92% of Patients Have Maintained Radiographic Progression-Free Survival at a Median of 12 Months ...

author_avatar
NASDAQ Market News